Pivotal study of Dupixent in moderate to severe atopic dermatitis in adolescents meets key endpoints May 16, 2018 No Comments
Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis May 7, 2018 No Comments
MOR-106 moves into phase II development for atopic dermatitis with IGUANA trial May 3, 2018 No Comments
RSS